Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...
The European Association of Dermato-Oncology classification flags the burden of difficult-to-treat tumours in transplant ...
Cervical squamous cell carcinoma is one of the predominant histological subtypes of cervical cancer, with significant morbidity and mortality globally. Its management increasingly relies on the ...
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of ...
Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or nonmelanoma skin cancer, which is also known as keratinocyte ...
The FDA approved cosibelimab (Unloxcyt) for treating metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) in adults who are not candidates for curative surgery or radiation.
Key market opportunities in cSCC clinical trials include identifying strategic investment areas, leveraging prominent trial locations to cut costs, and understanding trial success rates. The report's ...
Incyte on Friday said the positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use covers Zynyz in combination with platinum-based chemotherapy for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results